SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-12-000663
Filing Date
2012-10-02
Accepted
2012-10-02 17:04:50
Documents
2
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13D ss154309_sc13da.htm SC 13D/A 143936
2 JOINT FILING AGREEMENT ss154309_ex99a.htm EX-99.A 13753
  Complete submission text file 0000947871-12-000663.txt   159312
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 216-431-9900
ATHERSYS, INC / NEW (Subject) CIK: 0001368148 (see all company filings)

IRS No.: 204864095 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82141 | Film No.: 121124364
SIC: 2834 Pharmaceutical Preparations